Tectonic Therapeutic, Inc. Common Stock (TECX) Stock Price

TECXStock
$37.71+39.30%52W
Market Cap$737.21M
P/E
PEG Ratio
Div yield
Beta1.29

TECX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)61.43%
Price vs S&P 500 (4W)19.33%
VGM Score81.03

TECX Earnings Surprise History

Q2 25-1.07est. -0.98
Q3 25-1.02est. -1.05
Q4 25-1.03est. -1.11
Q1 26-1.34est. -1.17
Q2 26-1.18est. -1.35

TECX Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.25
4.31
4.31
4.31

Industry Peers — Biological Products(183)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
TECXTectonic Therapeutic, Inc. Common Stock
A$37.71
AMGNAmgen IncCCB$442.24
GILDGilead Sciences IncCBB$148.77
MRNAModerna, Inc. Common StockDCA$158.83
ARGXargenx SE American Depositary SharesDAB$1019.49
RVMDRevolution Medicines, Inc. Common StockFA$211.38
BIIBBiogen Inc. Common StockCDB$220.77
BNTXBioNTech SE American Depositary ShareCCB$114.05
NBIXNeurocrine Biosciences IncCBC$153.37
EXELExelixis IncCBB$56.72
HALOHalozyme Therapeutics, Inc.CBA$109.32

About Tectonic Therapeutic, Inc. Common Stock

Tectonic Therapeutics is a biotechnology company discovering and developing therapeutic proteins and antibodies that modulate GPCR function. Using its proprietary GEODe platform, the company designs biologic medicines to treat serious diseases with limited or no existing therapeutic options. The pipeline includes TX2100, a GPCR antagonist for hereditary hemorrhagic telangiectasia and fibrosis, and a program for pulmonary hypertension.